These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6810818)

  • 1. [Acute hemodynamic effects of prostacyclin in severe or malignant hypertension].
    Chaignon M; Tannière-Ruffie ML; Lucsko M; Guédon J
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():147-50. PubMed ID: 6810818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effects of intravenous prostacyclin in stable angina pectoris.
    Firth BG; Winniford MD; Campbell WB; Hillis LD
    Am J Cardiol; 1983 Sep; 52(5):439-43. PubMed ID: 6351580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term haemodynamic effects of enalapril at rest and during exercise in essential hypertension.
    Lund-Johansen P; Omvik P
    Scand J Urol Nephrol Suppl; 1984; 79():87-91. PubMed ID: 6089323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of prostacyclin in man.
    Szczeklik J; Szczeklik A; Nizankowski R
    Adv Prostaglandin Thromboxane Res; 1980; 7():769-75. PubMed ID: 6989203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N; Lundin S; Ricksten SE
    J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic and metabolic effects of prostacyclin after coronary bypass surgery.
    Chelly J; Fabiani JN; Chahine R; Tricot AM; Carpentier A; Passelecq J; Dubost C
    Circulation; 1982 Aug; 66(2 Pt 2):I45-9. PubMed ID: 7044613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
    Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G
    J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity and prediction of hemodynamic responses to dobutamine in patients with septic shock.
    Jellema WT; Groeneveld AB; Wesseling KH; Thijs LG; Westerhof N; van Lieshout JJ
    Crit Care Med; 2006 Sep; 34(9):2392-8. PubMed ID: 16849997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostacyclin therapy in patients with congestive heart failure.
    Yui Y; Nakajima H; Kawai C; Murakami T
    Am J Cardiol; 1982 Aug; 50(2):320-4. PubMed ID: 7048886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic effects of vasoactive agents following chronic state of high cardiac output in anaesthetized rats.
    Guo L; Tabrizchi R
    Eur J Pharmacol; 2008 May; 586(1-3):266-74. PubMed ID: 18367170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of long-term treatment with prostacyclin on plasma adrenomedullin in patients with primary pulmonary hypertension].
    Nakayama T; Ishikita T; Matsuura H; Saji T
    J Cardiol; 2001 Nov; 38(5):263-71. PubMed ID: 11729726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.
    Cabrol S; Souza R; Jais X; Fadel E; Ali RH; Humbert M; Dartevelle P; Simonneau G; Sitbon O
    J Heart Lung Transplant; 2007 Apr; 26(4):357-62. PubMed ID: 17403477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of atenolol in labile hypertension.
    González-Gómez A; García-Barreto D; Fránquiz JM
    Arch Int Pharmacodyn Ther; 1983 Feb; 261(2):260-7. PubMed ID: 6838285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension.
    Kähler CM; Graziadei I; Wiedermann CJ; Kneussl MP; Vogel W
    Wien Klin Wochenschr; 2000 Jul; 112(14):637-40. PubMed ID: 11008327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled prostacyclin following surgical repair of congenital heart disease--a pilot study.
    Carroll CL; Backer CL; Mavroudis C; Cook K; Goodman DM
    J Card Surg; 2005; 20(5):436-9. PubMed ID: 16153274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
    Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
    J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of nisoldipine in essential hypertension.
    Blau A; Herzog D; Herz I; Battler A; Schechter P; Eliahou HE
    Isr J Med Sci; 1994 Feb; 30(2):139-45. PubMed ID: 8150600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic effect of prazosin during hyperosmolar mannitol load in essential hypertension.
    Pechán J; Veres I; Ondrejka P
    Cor Vasa; 1989; 31(6):467-75. PubMed ID: 2517718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The control of hypertension with dibutyryl cyclic AMP.
    Sugai Y; Sugai K; Miyazaki M
    Eur J Anaesthesiol; 1987 May; 4(3):161-6. PubMed ID: 3036496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.